Quick Answer
Universe Pharmaceuticals INC reported Research And Development Expense of $671.76 million for the year ending 2025.
- Universe Pharmaceuticals INC showed a decrease of -77.8% in Research And Development Expense from 2024 to 2025.
- This data is from Universe Pharmaceuticals INC's annual report (Form 10-K), filed with the SEC on January 29, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Universe Pharmaceuticals INC's Research And Development Expense has grown by 108,522.4%.
- Historical annual values: Fiscal year 2025: $671.76 million | Fiscal year 2024: $3.03 billion | Fiscal year 2023: $4.86 billion | Fiscal year 2022: $7.64 million | Fiscal year 2021: $5.47 million | Fiscal year 2020: $583.1 thousand | Fiscal year 2019: $618.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: